Cognito Therapeutics and Ochsner partner for new brain health approaches
The Collaboratory leverages the expertise of Ochsner Health’s Neuroscience Institute.
Drug Development
Daiichi Sankyo and Tempus AI collaborate on ADC clinical development
Researchers become scientific tastemakers by handing more R&D to autonomous labs
Viz.ai and Alnylam to advance earlier identification of cardiac amyloidosis
MSD and Quotient collaborate on IBD drug targets
Monash University and ClinChoice partner on new therapies development
Kali and Sanofi sign licence agreement for KT501 autoimmune disease antibody
ImmunityBio receives Macau approval for Anktiva combo therapy
